Megan M Herr
26PUBLICATIONS
198CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (26)
Sort by Publication Date:
|Mar 28, 2026
Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium.Andrew J Portuguese, James A Davis, Shahzad Raza
|Mar 21, 2026
Efficacy of stem cell boost (SCB) for chimeric antigen receptor-T cell therapy (CAR-T)-related hematologic toxicity in patients with relapsed/refractory multiple myeloma (RRMM)-real world experience from the US multiple myeloma immunotherapy consortium.Cindy Varga, Myra Robinson, James A Davis
|Feb 02, 2026
Endogenous CD28 Drives the Persistent Activity of CAR T Cells in Myeloma and Lymphoma Models.Mackenzie M Lieberman, Jason H Tong, Nkechi U Odukwe
|Nov 28, 2025
The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience.Aimaz Afrough, Danai Dima, Beatrice Razzo
|Nov 14, 2025
Risk Factors beyond Chemotherapy Exposure for Secondary Myeloid Neoplasms after Hematologic Cancers: A SEER-Based Study.Abhay Singh, Theresa Hahn, Rahul Mishra
Pageof 5
Frequent Collaborators
14 joint publications
Surbhi Sidana
14 joint publications
James A Davis
13 joint publications
Krina Patel
13 joint publications
Jack Khouri
12 joint publications
Larry D Anderson
11 joint publications
Douglas W Sborov
11 joint publications
Doris K Hansen
10 joint publications
Rahul Banerjee
9 joint publications
Danai Dima
9 joint publications
Peter Voorhees